First-line osimertinib in elderly patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer: a retrospective multicenter study (HOT2002)

JOURNAL ARTICLE published 30 November 2021 in Scientific Reports

Authors: Gaku Yamamoto | Hajime Asahina | Osamu Honjo | Toshiyuki Sumi | Atsushi Nakamura | Kenichiro Ito | Hajime Kikuchi | Fumihiro Hommura | Ryoichi Honda | Keiki Yokoo | Yuka Fujita | Satoshi Oizumi | Ryo Morita | Yasuyuki Ikezawa | Hisashi Tanaka | Nozomu Kimura | Takaaki Sasaki | Noriaki Sukoh | Taichi Takashina | Toshiyuki Harada | Hirotoshi Dosaka-Akita | Hiroshi Isobe | Gaku Yamamoto | Hajime Asahina | Osamu Honjo | Toshiyuki Sumi | Atsushi Nakamura | Kenichiro Ito | Hiroshi Isobe | Hajime Kikuchi | Fumihiro Hommura | Ryoichi Honda | Keiki Yokoo | Yuka Fujita | Satoshi Oizumi | Ryo Morita | Yasuyuki Ikezawa | Hisashi Tanaka | Nozomu Kimura | Takaaki Sasaki | Noriaki Sukoh | Taichi Takashina | Toshiyuki Harada | Hirotoshi Akita | the Hokkaido Lung Cancer Clinical Study Group Trial